TSL-1806

N/A

Report date: 2023/04/13 10:01:19
NME

Base Information

Drug NameTSL-1806
Drug Alias NameTSL-1806
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 1 agonists
TargetsFree fatty acid receptor 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Tasly Diyi Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Tasly Diyi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A